We are live on ! Find out more
ACER

Acer Therapeutics Inc

Delisted

ACER was delisted on the 8th of November, 2023.

16 hedge funds and large institutions have $1.18M invested in Acer Therapeutics Inc in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

3% less capital invested

Capital invested by funds: $1.22M → $1.18M (-$41K)

11% less funds holding

Funds holding: 1816 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
2
Closed
6
Calls
Puts
Net Calls
Net Calls Change

ACER Hedge Fund Activity: Q2 2015 in Review

16 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2015, worth a combined $1.18M — down 3.4% from $1.22M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ACER and 4 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $171K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $275K sold.

  • 16 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2015, down from 18 in Q1 2015.
  • Funds reported $1.18M of Acer Therapeutics Inc stock for Q2 2015, down 3.4% quarter-over-quarter.
  • 4 funds opened new Acer Therapeutics Inc positions in Q2 2015 and 6 closed out, a net change of -2 holders.
  • The largest Acer Therapeutics Inc buyer in Q2 2015 was Renaissance Technologies, an estimated $171K added.
  • The largest Acer Therapeutics Inc seller in Q2 2015 was Hudson Bay Capital Management, an estimated $275K sold.

Based on aggregated 13F filings for Q2 2015.